AMVYX | JVMCX | AMVYX / JVMCX | |
Total Expense Ratio | 0.63 | 1.87 | 34% |
Annual Report Gross Expense Ratio | 0.63 | 1.88 | 34% |
Fund Existence | 8 years | 14 years | - |
Gain YTD | 7.157 | 8.696 | 82% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.09B | 23.1B | 31% |
Annual Yield % from dividends | 1.91 | 0.00 | - |
Returns for 1 year | 3.35 | -0.47 | -713% |
Returns for 3 years | 10.38 | 17.84 | 58% |
Returns for 5 years | 22.99 | 50.96 | 45% |
Returns for 10 years | N/A | 37.38 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LDVIX | 30.25 | 0.17 | +0.57% |
AXS FTSE Vntr Cptl RetTrckr I | |||
DYGIX | 14.79 | 0.04 | +0.27% |
Meeder Dynamic Allocation Institutional | |||
FLKSX | 16.06 | 0.03 | +0.19% |
Fidelity Low-Priced Stock K6 | |||
ETIHX | 34.88 | -0.02 | -0.06% |
Eventide Healthcare & Life Sciences I | |||
AEPCX | 58.83 | -0.31 | -0.52% |
American Funds EUPAC C |